Stocks and Investing Stocks and Investing
Wed, November 13, 2019
Tue, November 12, 2019

Robyn Karnauskas Initiated (BIIB) at Strong Buy and Held Target at $337 on, Nov 12th, 2019


Published on 2024-10-26 18:08:39 - WOPRAI, Robyn Karnauskas
  Print publication without navigation


Robyn Karnauskas of SunTrust Robinson Humphrey, Initiated "Biogen Inc." (BIIB) at Strong Buy and Held Target at $337 on, Nov 12th, 2019.

Robyn has made no other calls on BIIB in the last 4 months.



There are 10 other peers that have a rating on BIIB. Out of the 10 peers that are also analyzing BIIB, 3 agree with Robyn's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Cory Kasimov of "JP Morgan" Maintained at Hold with Increased Target to $260 on, Wednesday, October 23rd, 2019
  • Ian Somaiya of "BMO Capital" Maintained at Hold with Increased Target to $297 on, Wednesday, October 23rd, 2019
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Hold with Increased Target to $305 on, Wednesday, October 23rd, 2019


These are the ratings of the 7 analyists that currently disagree with Robyn


  • Aaron Gal of "Bernstein" Upgraded from Hold to Buy on, Wednesday, October 30th, 2019
  • Adnan Butt of "Guggenheim" Upgraded from Hold to Strong Buy on, Wednesday, October 23rd, 2019
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $335 on, Wednesday, October 23rd, 2019
  • Evan Seigerman of "Credit Suisse" Maintained at Sell with Increased Target to $260 on, Wednesday, October 23rd, 2019
  • Marc Goodman of "SVB Leerink" Upgraded from Hold to Buy and Increased Target to $350 on, Wednesday, October 23rd, 2019
  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Increased Target to $262 on, Wednesday, October 23rd, 2019
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Increased Target to $325 on, Wednesday, October 23rd, 2019
Contributing Sources